S
Srividhya
About Srividhya
Data last updated:
Srividhya is a Company Secretary at Regenix Drugs Limited (since 2016), Company Secretary at Regenix Biosciences Limited (since 2019) and Director at Gamifysoft Private Limited (since 2025), and holds 1 more current directorship. The companies operate in Healthcare and Information Technology. The 3 current companies with reported revenue have a combined latest revenue of ₹199 Cr; the largest is Regenix Drugs Limited at ₹188 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Regenix Drugs Limited U24232TN2007PLC063446 | Company Secretary | 28 Sep 2016 | 2007 | ₹188 Cr (FY 2024) | Active |
 Regenix Biosciences Limited U24100TN2006PLC059065 | Company Secretary | 01 May 2019 | 2006 | ₹6.81 Cr (FY 2025) | Active |
 Gamifysoft Private Limited U72900KA2021PTC155540 | Director | 16 Apr 2025 | 2021 | ₹4.09 Cr (FY 2025) | Active |
| Pratique Learning Hub Private Limited U85500TN2025PTC187521 | Additional Director | 30 Dec 2025 | 2025 | Active |
Board colleagues of Srividhya
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Srividhya
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Srividhya
Srividhya currently holds 4 directorships: Regenix Drugs Limited (Company Secretary, since 28 Sep 2016, revenue ₹188 Cr (FY 2024)); Regenix Biosciences Limited (Company Secretary, since 01 May 2019, revenue ₹6.81 Cr (FY 2025)); Gamifysoft Private Limited (Director, since 16 Apr 2025, revenue ₹4.09 Cr (FY 2025)); Pratique Learning Hub Private Limited (Additional Director, since 30 Dec 2025).
Srividhya was first appointed on 28 Sep 2016 as Company Secretary at Regenix Drugs Limited. The most recent appointment on record is 30 Dec 2025 at Pratique Learning Hub Private Limited.
The 3 current companies of Srividhya that report revenue have a combined latest revenue of ₹199 Cr: Regenix Drugs Limited ₹188 Cr (FY 2024); Regenix Biosciences Limited ₹6.81 Cr (FY 2025); Gamifysoft Private Limited ₹4.09 Cr (FY 2025).
The current boards of Srividhya's companies include Akshay Arvind (Regenix Drugs Limited), Ayyamperumal (Regenix Drugs Limited), Balaji Ramamurthy (Regenix Drugs Limited), Govindarajan Venkatakrishna (Regenix Drugs Limited), Guhan Ramamurthy (Regenix Drugs Limited), Gunasekaran Raju (Regenix Drugs Limited), among others.